Literature DB >> 9155847

Nebulizer therapy. Guidelines. British Thoracic Society Nebulizer Project Group.

.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9155847      PMCID： PMC1765861          DOI： 10.1136/thx.52.2008.s4

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  9 in total

1.  Design characteristics for drug nebulizers.

Authors:  J H Dennis; D J Hendrick
Journal:  J Med Eng Technol       Date:  1992 Mar-Apr

2.  Nebulised water as a bronchoconstricting challenge in infancy.

Authors:  C O'Callaghan; A D Milner; M S Webb; A Swarbrick
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

3.  Bacterial contamination of home nebuliser.

Authors:  K L Barnes; R Clifford; S T Holgate; D Murphy; P Comber; E Bell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-03

4.  Emergency use of nebulised bronchodilator drugs in British hospitals.

Authors:  B R O'Driscoll; G M Cochrane
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

5.  Nebulizers--fill volume, residual volume and matching of nebulizer to compressor.

Authors:  A H Kendrick; E C Smith; J Denyer
Journal:  Respir Med       Date:  1995-03       Impact factor: 3.415

6.  Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").

Authors:  D M Newnham; B J Lipworth
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

Review 7.  Delivering optimal care to the person with asthma: what are the key components and what do we mean by patient education?

Authors:  M R Partridge
Journal:  Eur Respir J       Date:  1995-02       Impact factor: 16.671

8.  Oxygen as a driving gas for nebulisers: safe or dangerous?

Authors:  K A Gunawardena; B Patel; I A Campbell; J B MacDonald; A P Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

Review 9.  Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis.

Authors:  H M Bryson; E M Sorkin
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546
  9 in total
  5 in total

Review 1.  Once-daily inhaled corticosteroids in children with asthma: nebulisation.

Authors:  G Shapiro
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 2.  Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.

Authors:  K M Hvizdos; B Jarvis
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

3.  Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline.

Authors:  Brenda M Button; Christine Wilson; Ruth Dentice; Narelle S Cox; Anna Middleton; Esta Tannenbaum; Jennifer Bishop; Robyn Cobb; Kate Burton; Michelle Wood; Fiona Moran; Ryan Black; Summar Bowen; Rosemary Day; Julie Depiazzi; Katherine Doiron; Michael Doumit; Tiffany Dwyer; Alison Elliot; Louise Fuller; Kathleen Hall; Matthew Hutchins; Melinda Kerr; Annemarie L Lee; Christina Mans; Lauren O'Connor; Ranjana Steward; Angela Potter; Tshepo Rasekaba; Rebecca Scoones; Ben Tarrant; Nathan Ward; Samantha West; Dianne White; Lisa Wilson; Jamie Wood; Anne E Holland
Journal:  Respirology       Date:  2016-04-18       Impact factor: 6.424

4.  Inhaled steroid/tobacco smoke particle interactions: a new light on steroid resistance.

Authors:  Giovanni Invernizzi; Ario Ruprecht; Cinzia De Marco; Roberto Mazza; Gabriele Nicolini; Roberto Boffi
Journal:  Respir Res       Date:  2009-06-11

5.  Characterization of a human powered nebulizer compressor for resource poor settings.

Authors:  Christopher J Hallberg; Mary Therese Lysaught; Christopher E Zmudka; William K Kopesky; Lars E Olson
Journal:  Biomed Eng Online       Date:  2014-06-16       Impact factor: 2.819
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.